News

Synapse Dental and Smiles Change Lives Help Underserved Communities With Affordable and Now Pain-Free Orthodontics

CRANSTON, R.I., April 12, 2023 (GLOBE NEWSWIRE) -- If you’ve ever had braces to create a beautiful smile, you’ll know…

2 years ago

NCPDP Selects H1 as Exclusive Provider Data Partner

NCPDP’s robust prescriber database, HCIdea, is now powered by H1’s trusted provider data to help NCPDP members reduce costs and…

2 years ago

Celularity’s Dr. Robert Hariri To Co-Chair The 2023 International Precision Medicine Center (IPMC) Conference “Beyond Longevity: Live 120 Like 50™”

Hariri, Celularity’s CEO, Chairman and Founder, will open the meeting with the keynote address highlighting recent progress and important next…

2 years ago

Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights

– 2022 marks Ceapro’s best performance in Company history with record sales of $18,800,000 compared to $17,200,000 for 2021, representing…

2 years ago

Tenax Therapeutics Provides 2023 Business Update

Company to prioritize the clinical development of TNX-103 (oral levosimendan) for the treatment of pulmonary hypertension and heart failure with…

2 years ago

AIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W. Neal Burnette, Ph.D., as Chairman of its Scientific Advisory Board (SAB)

Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry OCALA, Fla., April 12,…

2 years ago

Teladoc Health to Announce First Quarter 2023 Financial Results

PURCHASE, NY, April 12, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,…

2 years ago

Century Therapeutics Announces Leadership Changes

– Lalo Flores, Ph.D., steps down as Chief Executive Officer and member of Board of Directors; Greg Russotti, Ph.D., Chief Technology…

2 years ago

First Patient Enrolled in JDRF-Funded Phase II Trial of CPP-1X-T for Recent Onset Type I Diabetes, Led by Indiana University School of Medicine

MINNEAPOLIS, April 12, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the…

2 years ago